Quantum

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple…

In March 2022 I wrote a description of the Quantum Technology Ecosystem. I thought this would be a good time to check in on the progress of building a quantum…